Cancer Incidence and Mortality among Hispanic Individuals, New York State Excl New York City, 2016-2020
Source: New York State Cancer Registry
Site of Cancer | Incidence | Mortality | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
All Invasive Malignant Tumors | 3,522.4 | 382.3 | 376.3-388.4 | 1,684.6 | 413.5 | 403.8-423.3 | 1,837.8 | 366.8 | 359.0-374.6 | 777.0 | 96.0 | 92.9-99.3 | 387.8 | 111.7 | 106.4-117.2 | 389.2 | 85.6 | 81.7-89.6 |
Oral cavity and pharynx | 81.6 | 8.8 | 8.0-9.8 | 55.8 | 13.1 | 11.5-14.9 | 25.8 | 5.2 | 4.3-6.3 | 14.2 | 1.8 | 1.4-2.3 | 10.4 | 3.1 | 2.3-4.1 | 3.8 | 0.8 | 0.5-1.3 |
Esophagus | 24.0 | 3.1 | 2.5-3.7 | 20.4 | 5.9 | 4.7-7.2 | 3.6 | 0.9 | 0.5-1.4 | 11.4 | 1.4 | 1.1-1.9 | 9.4 | 2.7 | 1.9-3.6 | 2.0 | 0.5 | 0.2-0.9 |
Stomach | 103.4 | 11.7 | 10.7-12.8 | 55.4 | 13.6 | 11.9-15.4 | 48.0 | 10.3 | 9.0-11.7 | 36.6 | 4.3 | 3.7-5.0 | 19.6 | 5.3 | 4.2-6.6 | 17.0 | 3.7 | 2.9-4.5 |
Colorectal | 292.8 | 32.1 | 30.4-33.9 | 150.6 | 35.2 | 32.5-38.1 | 142.2 | 29.5 | 27.3-31.8 | 66.4 | 8.1 | 7.2-9.0 | 34.8 | 9.6 | 8.1-11.3 | 31.6 | 7.0 | 5.9-8.2 |
Colon excluding rectum | 198.6 | 22.6 | 21.1-24.2 | 95.8 | 23.7 | 21.4-26.1 | 102.8 | 21.9 | 19.9-23.9 | 50.8 | 6.3 | 5.5-7.2 | 25.0 | 7.2 | 5.9-8.7 | 25.8 | 5.7 | 4.8-6.9 |
Rectum & rectosigmoid | 94.2 | 9.5 | 8.6-10.4 | 54.8 | 11.6 | 10.1-13.2 | 39.4 | 7.6 | 6.6-8.8 | 15.6 | 1.7 | 1.4-2.2 | 9.8 | 2.4 | 1.7-3.2 | 5.8 | 1.2 | 0.8-1.7 |
Liver / intrahepatic bile duct | 104.8 | 12.3 | 11.2-13.4 | 70.0 | 17.8 | 15.8-19.9 | 34.8 | 7.8 | 6.6-9.0 | 64.4 | 8.0 | 7.1-8.9 | 42.2 | 11.5 | 9.9-13.3 | 22.2 | 5.2 | 4.2-6.2 |
Pancreas | 110.2 | 13.2 | 12.1-14.4 | 54.4 | 14.1 | 12.3-16.0 | 55.8 | 12.4 | 11.0-14.0 | 62.4 | 7.8 | 6.9-8.7 | 31.2 | 8.5 | 7.1-10.0 | 31.2 | 7.1 | 6.0-8.4 |
Larynx | 23.4 | 2.6 | 2.1-3.2 | 19.8 | 4.9 | 3.9-6.1 | 3.6 | 0.7 | 0.4-1.2 | 5.0 | 0.7 | 0.4-1.0 | 3.6 | 1.2 | 0.7-1.8 | 1.4 | 0.3 | 0.1-0.7 |
Lung and bronchus | 278.0 | 35.3 | 33.4-37.3 | 141.2 | 42.0 | 38.8-45.5 | 136.8 | 30.7 | 28.3-33.1 | 112.4 | 14.6 | 13.3-15.9 | 66.4 | 20.2 | 17.9-22.6 | 46.0 | 10.4 | 9.1-11.9 |
Melanoma of the skin | 38.6 | 4.4 | 3.8-5.1 | 23.4 | 6.1 | 5.0-7.5 | 15.2 | 3.2 | 2.5-4.1 | 5.2 | 0.5 | 0.3-0.8 | 2.8 | 0.6 | 0.3-1.0 | 2.4 | 0.5 | 0.2-0.9 |
Female breast | 545.2 | 105.6 | 101.5-109.7 | 60.8 | 12.5 | 11.1-14.1 | ||||||||||||
Cervix uteri | 45.0 | 8.1 | 7.0-9.2 | 8.8 | 1.6 | 1.2-2.2 | ||||||||||||
Corpus uterus and NOS | 117.4 | 23.1 | 21.2-25.1 | 18.6 | 4.1 | 3.3-5.0 | ||||||||||||
Ovary | 49.6 | 9.3 | 8.1-10.6 | 19.4 | 4.1 | 3.3-5.0 | ||||||||||||
Prostate | 423.4 | 105.7 | 100.9-110.6 | 34.8 | 12.7 | 10.8-14.8 | ||||||||||||
Testis | 31.4 | 4.3 | 3.7-5.1 | 1.8 | 0.3 | 0.1-0.5 | ||||||||||||
Urinary bladder (incl. in situ) | 101.4 | 13.2 | 12.0-14.5 | 77.0 | 23.1 | 20.7-25.7 | 24.4 | 5.7 | 4.7-6.8 | 16.0 | 2.4 | 1.9-3.0 | 11.4 | 4.2 | 3.1-5.4 | 4.6 | 1.2 | 0.7-1.7 |
Kidney and renal pelvis | 128.0 | 13.3 | 12.2-14.4 | 81.6 | 18.1 | 16.2-20.1 | 46.4 | 9.2 | 8.0-10.5 | 14.8 | 1.8 | 1.4-2.3 | 9.2 | 2.3 | 1.6-3.2 | 5.6 | 1.4 | 0.9-2.0 |
Brain and other central nervous system | 64.0 | 5.7 | 5.1-6.4 | 38.2 | 7.1 | 6.0-8.3 | 25.8 | 4.5 | 3.7-5.3 | 26.2 | 2.6 | 2.2-3.2 | 14.8 | 3.1 | 2.4-4.0 | 11.4 | 2.2 | 1.7-2.9 |
Thyroid | 198.0 | 16.8 | 15.7-17.9 | 40.2 | 6.9 | 6.0-8.0 | 157.8 | 26.9 | 25.0-28.9 | 3.4 | 0.4 | 0.2-0.7 | 1.2 | 0.3 | 0.1-0.7 | 2.2 | 0.5 | 0.3-0.9 |
Hodgkin lymphoma | 31.2 | 2.8 | 2.3-3.3 | 18.4 | 3.3 | 2.6-4.1 | 12.8 | 2.3 | 1.7-2.9 | 2.2 | 0.3 | 0.1-0.5 | 1.0 | 0.2 | 0.1-0.5 | 1.2 | 0.3 | 0.1-0.6 |
Non-Hodgkin lymphomas | 182.2 | 19.9 | 18.5-21.3 | 98.2 | 23.9 | 21.6-26.3 | 84.0 | 17.0 | 15.3-18.7 | 29.0 | 3.9 | 3.3-4.6 | 15.0 | 4.9 | 3.8-6.2 | 14.0 | 3.2 | 2.5-4.1 |
Myeloma | 69.0 | 7.9 | 7.1-8.8 | 37.2 | 9.3 | 7.9-10.8 | 31.8 | 6.8 | 5.7-7.9 | 16.4 | 2.2 | 1.7-2.7 | 7.0 | 2.2 | 1.5-3.1 | 9.4 | 2.1 | 1.6-2.9 |
Leukemias | 132.0 | 13.4 | 12.4-14.6 | 76.8 | 17.4 | 15.5-19.4 | 55.2 | 10.4 | 9.2-11.8 | 37.2 | 4.2 | 3.6-4.9 | 22.6 | 5.6 | 4.5-6.8 | 14.6 | 3.1 | 2.4-3.9 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.